172 related articles for article (PubMed ID: 20622918)
1. The impact of adherence and disease control on resource use and charges in patients with mild asthma managed on inhaled corticosteroid agents.
Navaratnam P; Friedman HS; Urdaneta E
Patient Prefer Adherence; 2010 Jun; 4():197-205. PubMed ID: 20622918
[TBL] [Abstract][Full Text] [Related]
2. Mometasone furoate versus beclomethasone dipropionate: effectiveness in patients with mild asthma.
Friedman HS; Urdaneta E; McLaughlin JM; Navaratnam P
Am J Manag Care; 2010 Jul; 16(7):e151-6. PubMed ID: 20645660
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth.
Pruteanu AI; Chauhan BF; Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):931-1046. PubMed ID: 25504973
[TBL] [Abstract][Full Text] [Related]
4. Inhaled Budesonide vis-à-vis Inhaled Mometasone in Chinese Children with Mild Persistent Asthma: A Single-Center, Retrospective Study.
Gao P; Ding Y; Yin B; Gu H
Pharmacology; 2021; 106(11-12):616-622. PubMed ID: 34518479
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009471. PubMed ID: 25030198
[TBL] [Abstract][Full Text] [Related]
7. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.
Navaratnam P; Friedman HS; Urdaneta E
Value Health; 2011; 14(2):339-46. PubMed ID: 21402302
[TBL] [Abstract][Full Text] [Related]
8. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
Sharpe M; Jarvis B
Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026
[TBL] [Abstract][Full Text] [Related]
9. Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database.
Atsuta R; Takai J; Mukai I; Kobayashi A; Ishii T; Svedsater H
Pulm Ther; 2018 Dec; 4(2):135-147. PubMed ID: 32026395
[TBL] [Abstract][Full Text] [Related]
10. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder.
Hagiwara M; Delea TE; Stanford RH
J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687
[TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges.
Navaratnam P; Friedman HS; Urdaneta E
Curr Med Res Opin; 2009 Dec; 25(12):2895-901. PubMed ID: 19821655
[TBL] [Abstract][Full Text] [Related]
12. Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs.
Averell CM; Stanford RH; Laliberté F; Wu JW; Germain G; Duh MS
J Asthma; 2021 Jan; 58(1):102-111. PubMed ID: 31607180
[TBL] [Abstract][Full Text] [Related]
13. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
Karpel JP; Nelson H
Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth.
Pruteanu AI; Chauhan BF; Zhang L; Prietsch SO; Ducharme FM
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009878. PubMed ID: 25030199
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology Versus Convenience: A Benefit/Risk Analysis of Regular Maintenance Versus Infrequent or As-Needed Inhaled Corticosteroid Use in Mild Asthma.
Daley-Yates P; Aggarwal B; Lulic Z; Fulmali S; Cruz AA; Singh D
Adv Ther; 2022 Jan; 39(1):706-726. PubMed ID: 34873657
[TBL] [Abstract][Full Text] [Related]
17. Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
van Zyl-Smit RN; Krüll M; Gessner C; Gon Y; Noga O; Richard A; de Los Reyes A; Shu X; Pethe A; Tanase AM; D'Andrea P;
Lancet Respir Med; 2020 Oct; 8(10):987-999. PubMed ID: 32653075
[TBL] [Abstract][Full Text] [Related]
18. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
Daley-Yates PT; Deans A; Mehta R; Sousa AR
Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
[TBL] [Abstract][Full Text] [Related]
20. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
